awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34166256-2CDC96C5-4C3E-4E39-8B23-49CB53FC243A
Q34166256-2CDC96C5-4C3E-4E39-8B23-49CB53FC243A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34166256-2CDC96C5-4C3E-4E39-8B23-49CB53FC243A
Drug development for Alzheimer's disease: where are we now and where are we headed?
P2860
Q34166256-2CDC96C5-4C3E-4E39-8B23-49CB53FC243A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34166256-2CDC96C5-4C3E-4E39-8B23-49CB53FC243A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c130a6086d1c81760cb1aa0f65188cda3f8de0b4
P2860
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.